文献速递前列腺癌前列腺增生与排尿功能障碍

前列腺癌患者中HoLEP、ThuLEP与TURP的围手术期结局:GRAND研究

Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2025-05-19

基于德国全国住院数据(GRAND)2005–2022年221,768例前列腺癌患者的前列腺手术,比较HoLEP、ThuLEP与TURP的围手术期结局。TURP仍占主导但激光剜除术使用显著增加,至2022年占17%。TURP的输血率(8.8%)和ICU入住率(1.7%)高于HoLEP和ThuLEP(分别为2.5%和≤1.2%),激光剜除术的术后尿潴留和尿失禁率也更低。

要点

  • 前列腺癌患者中TURP围手术期结局劣于HoLEP和ThuLEP。
  • TURP输血率8.8%、ICU入住率1.7%,HoLEP和ThuLEP分别为2.5%和≤1.2%。
  • HoLEP和ThuLEP的结局不受前列腺癌状态影响,而TURP在前列腺癌患者中更差。

核心结论

  • 在前列腺癌患者中,HoLEP和ThuLEP的围手术期结局优于TURP。

研究设计与样本

  • 使用德国全国住院数据(GRAND)注册库,纳入2005–2022年诊断为前列腺癌并接受HoLEP、ThuLEP或TURP的男性患者。
  • 共分析221,768例手术:HoLEP 8,160例,ThuLEP 2,285例,TURP 211,323例。
  • 采用多变量回归分析比较围手术期发病率和死亡率。

主要发现

  • TURP仍为主要术式,但HoLEP和ThuLEP使用近年显著增加,至2022年占所有病例的17%。
  • TURP输血率8.8%、ICU入住率1.7%,高于HoLEP和ThuLEP(分别为2.5%和≤1.2%)。
  • 激光剜除术的术后尿潴留和尿失禁率低于TURP。
  • 前列腺癌患者接受TURP的围手术期结局劣于无前列腺癌者,而HoLEP和ThuLEP的结局与前列腺癌状态无关。

临床怎么用

  • 前列腺癌患者需行经尿道前列腺手术时,可优先考虑HoLEP或ThuLEP以降低围手术期并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited data exist on the role of holmium laser enucleation of the prostate (HoLEP), thulium laser enucleation of the prostate (ThuLEP), and transurethral resection of the prostate (TURP) in patients with prostate cancer (PCa). We aimed to analyze their perioperative outcomes and trends. MATERIALS AND METHODS: The German Nationwide Inpatient Data (GRAND) registry was used to identify male patients diagnosed with PCa who underwent HoLEP, ThuLEP, or TURP between 2005 and 2022. Multivariable regression analyses were performed to compare perioperative morbidity and mortality. RESULTS: A total of 221,768 procedures in patients with PCa were performed: 8160 HoLEP, 2285 ThuLEP, and 211,323 TURP. Although TURP remains the predominant technique, the use of HoLEP and ThuLEP has increased significantly in recent years, representing 17% of all cases by 2022. Perioperative outcomes were worse for TURP, with higher transfusion (8.8%) and ICU admission rates (1.7%) compared to HoLEP and ThuLEP (both 2.5% and ≤1.2%, respectively). Postoperative urinary retention and incontinence rates were also lower for laser enucleation techniques than TURP. In patients with PCa undergoing TURP, perioperative outcomes were worse compared to those without PCa, while outcomes for HoLEP and ThuLEP were comparable regardless of PCa status. CONCLUSION: HoLEP and ThuLEP offer improved perioperative outcomes compared to TURP in patients with PCa.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Pyrgidis N, Schulz GB, Weinhold P, et al. Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study. Prostate Cancer Prostatic Dis. 2025. PMID: 40389710. doi:10.1038/s41391-025-00980-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。